These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23907402)

  • 1. The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
    Watt ML; Rorick-Kehn L; Shaw DB; Knitowski KM; Quets AT; Chesterfield AK; McKinzie DL; Felder CC
    Neuropsychopharmacology; 2013 Dec; 38(13):2717-26. PubMed ID: 23907402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance.
    Rasmussen T; Fink-Jensen A; Sauerberg P; Swedberg MD; Thomsen C; Sheardown MJ; Jeppesen L; Calligaro DO; DeLapp NW; Whitesitt C; Ward JS; Shannon HE; Bymaster FP
    Schizophr Res; 2001 Apr; 49(1-2):193-201. PubMed ID: 11343877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
    Joseph L; Thomsen M
    Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.
    Leach K; Loiacono RE; Felder CC; McKinzie DL; Mogg A; Shaw DB; Sexton PM; Christopoulos A
    Neuropsychopharmacology; 2010 Mar; 35(4):855-69. PubMed ID: 19940843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.
    Hemrick-Luecke SK; Bymaster FP; Evans DC; Wess J; Felder CC
    J Pharmacol Exp Ther; 2002 Oct; 303(1):99-103. PubMed ID: 12235238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-like effect of the muscarinic acetylcholine receptor agonist BuTAC in non-human primates.
    Andersen MB; Croy CH; Dencker D; Werge T; Bymaster FP; Felder CC; Fink-Jensen A
    PLoS One; 2015; 10(4):e0122722. PubMed ID: 25880220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.
    Byun NE; Grannan M; Bubser M; Barry RL; Thompson A; Rosanelli J; Gowrishankar R; Kelm ND; Damon S; Bridges TM; Melancon BJ; Tarr JC; Brogan JT; Avison MJ; Deutch AY; Wess J; Wood MR; Lindsley CW; Gore JC; Conn PJ; Jones CK
    Neuropsychopharmacology; 2014 Jun; 39(7):1578-93. PubMed ID: 24442096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
    Bubser M; Bridges TM; Dencker D; Gould RW; Grannan M; Noetzel MJ; Lamsal A; Niswender CM; Daniels JS; Poslusney MS; Melancon BJ; Tarr JC; Byers FW; Wess J; Duggan ME; Dunlop J; Wood MW; Brandon NJ; Wood MR; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2014 Oct; 5(10):920-42. PubMed ID: 25137629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.
    Dencker D; Wörtwein G; Weikop P; Jeon J; Thomsen M; Sager TN; Mørk A; Woldbye DP; Wess J; Fink-Jensen A
    J Neurosci; 2011 Apr; 31(16):5905-8. PubMed ID: 21508215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice.
    Zhang HM; Chen SR; Matsui M; Gautam D; Wess J; Pan HL
    Mol Pharmacol; 2006 Mar; 69(3):1048-55. PubMed ID: 16365281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
    Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
    Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S; Dolezal V; Popham A; Birdsall NJ
    Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice.
    Chen SR; Wess J; Pan HL
    J Pharmacol Exp Ther; 2005 May; 313(2):765-70. PubMed ID: 15665136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors.
    Michal P; Lysíková M; El-Fakahany EE; Tucek S
    Eur J Pharmacol; 1999 Jul; 376(1-2):119-25. PubMed ID: 10440097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.
    Tzavara ET; Bymaster FP; Felder CC; Wade M; Gomeza J; Wess J; McKinzie DL; Nomikos GG
    Mol Psychiatry; 2003 Jul; 8(7):673-9. PubMed ID: 12874603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
    Olianas MC; Maullu C; Onali P
    Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
    Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
    Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.
    Croy CH; Chan WY; Castetter AM; Watt ML; Quets AT; Felder CC
    Eur J Pharmacol; 2016 Jul; 782():70-6. PubMed ID: 27085897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.